Latest Stock Buy or Sell? Make More Informed Decisions!
Today, Brian Acker, CA commented about whether LOW-N, RON-T, PTI-T, GOOG-Q, PG-N, NCC-N, UUU-T, ETFC-Q, ACAS-Q, CNR-T, BAC-N, COF-N, SW-T, MX-T, S-N, VRX-T, AEM-T, NA-T, CM-T, INTC-Q, AMD-Q, CTC.A-T, NXY-T, OXY-N, PFE-N, PCA-T, TECK.B-T, MS-N, C-N are stocks to buy or sell.
- Page 1/3
- Next Page
TOP PICK
His model price is $46.49, a 54% positive differential. He put it through a stress test. They announced they were going to write off $7 billion to $11 billion and he used the figure of $15 billion. He took one analysts estimate of $290 for 08 and he used $284. Doing all this, his model price still came out to $37.00. They have ample capital to get them through this.
banks
PAST TOP PICK
(A Past Top Pick Dec 21/06. Down 10.8%.) This one is probably the bane of all the value managers. Even boosted their dividend by 10%. His model price is $40.53, a 74% positive differential. If they could do anything to thin out that balance sheet, it would be a huge positive for the stock.
biotechnology
pharmaceutical
COMMENT
Model price has been coming off as earnings estimates have been creeping down. Model price is $81.89. Was probably $92 in September $92. Under pressure because fundamentals have been coming down. When you see a turnaround in the Canadian economy, there could be some positive earnings estimates coming through. That's when the stock should either base or start to turn upward.
specialty stores
